Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis (RHEO-AMD)

This study has suspended participant recruitment.
(In light of the company's current financial position we have indefinately suspended the Rheo-AMD trial.)
Information provided by:
OccuLogix Identifier:
First received: April 16, 2007
Last updated: November 6, 2007
Last verified: April 2007
No Study Results Posted on for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: December 2009
  Estimated Primary Completion Date: No date given